• Prescription Drug
  • Regulation

CMS Issues Pair of Rules on Line Item Extension Drugs

March 29, 2019


The Centers for Medicare and Medicaid Services (CMS) has issued an interim final rule revising the calculation of rebates for line item extension drugs and a final rule declining to finalize proposed regulatory change to the definition of “line item extension drugs.”

Comments on the rules are due in late May.

Previous Post / Next Post
beakernav X1E2BFA62-BFCE-43C1-B777-27E3E5216018medical bagoriginal analysis +external linkpdf downloadstethoscope